Exemestane

3 Drugs classified under this active ingredient

Aromatase Inhibitor. Exemestane 25 mg.
TABS: 30. 1 tab (25 mg) dly. aft. meals.
See lit.
Advanced breast cancer (ABC) in women
with natural/induced post-menopaus.
status (progress. foll. anti-estrogen ther.
alone) and in post-menopaus. women
(progress. foll. multiple hormonal
therapies). Adjuv. tmt post-menopaus.
women with estrogen receptor pos. invas.
early breast cancer foll. 2-3 yrs of initial
adjuv. ther.
C/I: Hypersens., premenopaus., pregn.,
lact.

Aromatase Inhibitor. Exemestane 25 mg.
COAT. TABS.:30. One tab. (25 mg)×1/d. See lit.
Tmt. of advanced breast cancer (ABC) in women with natural or induced postmenopaus. status whose disease has progres. follow. anti-oestrogen ther. alone. Tmt. of postmenopaus. women with ABC whose dis. has progres. follow. multiple hormone. therapies.
Indicated for the adjuvant tmt. of postmenopaus. women with oestrogen receptor positive invas. early breast cancer follow. 2-3 years of init. adjuvant tamoxifen ther.
C/I: Hypersens. Pregnancy. Lactation.
Women of child bear. potential.

Aromatase Inhibitor. Exemestane 25 mg.
F.C.TABS: 25 mg: x 10, 14, 15, 20, 28, 30,
50, 60, 90, 98, 100, 120 tab.
1 tab (25 mg) dly. aft. meals.
Tmt. of advanced breast cancer (ABC) in
women with nat./ induc. postmenopaus.
status (progress. foll. anti-estrogen ther.
alone); Tmt. of postmenopaus. women
with ABC whose disease has progress. foll.
multiple hormonal ther. Adjuv. tmt. of postmenopaus. women with estrogen
receptor pos. invas. early breast cancer foli.
2-3 years of initial adjuv. tamoxifen ther.
C/I: Hypersens., premenopaus., pregn.,
lact.